Cargando…

Clinical Utility of Definitive Drug–Drug Interaction Testing in Primary Care

Drug–drug interactions (DDIs) are a leading cause of morbidity and mortality. New tools are needed to improve identification and treatment of DDIs. We conducted a randomized controlled trial to assess the clinical utility of a new test to identify DDIs and improve their management. Primary care phys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peabody, John, Tran, Mary, Paculdo, David, Schrecker, Joshua, Valdenor, Czarlota, Jeter, Elaine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262337/ https://www.ncbi.nlm.nih.gov/pubmed/30366371 http://dx.doi.org/10.3390/jcm7110384

Ejemplares similares

Establishing Clinical Utility for Diagnostic Tests Using a Randomized Controlled, Virtual Patient Trial Design
por: Peabody, John, et al.
Publicado: (2019)

Clinical Variation in the Treatment Practices for Medication Nonadherence, Drug–Drug Interactions, and Recognition of Disease Progression in Patients with Chronic Cardiometabolic Diseases: A Cross-Sectional Patient Simulation Study among Primary Care Physicians
por: Valdenor, Czarlota, et al.
Publicado: (2022)

Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease
por: Peabody, John W, et al.
Publicado: (2023)

Drug-Drug Interaction Assessment and Identification in the Primary Care Setting
por: Peabody, John, et al.
Publicado: (2018)

Randomized Trial to Improve Primary Care Patient Management and Patient Outcomes Using a Drug–Drug Interaction Test: Confirmation of the DECART Simulated Patient Clinical Utility Trial Results
por: Peabody, John, et al.
Publicado: (2021)

Variation in Assessing Renal Allograft Rejection: A National Assessment of Nephrology Practice
por: Peabody, John, et al.
Publicado: (2019)

Measuring and Improving Evidence-Based Patient Care Using a Web-Based Gamified Approach in Primary Care (QualityIQ): Randomized Controlled Trial
por: Burgon, Trever, et al.
Publicado: (2021)

Standardising practice in cardiology: reducing clinical variation and cost at Ochsner Health System
por: Oravetz, Phil, et al.
Publicado: (2019)

Impact of Definitive Drug–Drug Interaction Testing on Medication Management and Patient Care
por: Arnold, Renée J. G., et al.
Publicado: (2018)

Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners
por: Peabody, John, et al.
Publicado: (2020)

Randomized Trial on the Clinical Utility of a Novel Biomarker Panel to Identify Treatable Determinants of Chronic Pain
por: Peabody, John, et al.
Publicado: (2020)

A nationwide program to improve clinical care quality in the Kyrgyz Republic
por: Peabody, John W, et al.
Publicado: (2020)

Clinical utility of a novel test for assessing cardiovascular disease risk in type 2 diabetes: a randomized controlled trial
por: Peabody, John W., et al.
Publicado: (2023)

Clinical Variation in the Treatment Practices for Patients With Type 2 Diabetes: A Cross‐Sectional Patient Simulation Study Among Primary Care Physicians and Cardiologists
por: De Belen, Enrico, et al.
Publicado: (2023)

Clinical Utility of a Comprehensive, Whole Genome CMA Testing Platform in Pediatrics: A Prospective Randomized Controlled Trial of Simulated Patients in Physician Practices
por: Peabody, John, et al.
Publicado: (2016)

Formalizing Evidence Type Definitions for Drug-Drug Interaction Studies to Improve Evidence Base Curation
por: Utecht, Joseph, et al.
Publicado: (2017)

Gaps in the Care of Pulmonary Hypertension: A Cross‐Sectional Patient Simulation Study Among Practicing Cardiologists and Pulmonologists
por: de Belen, Enrico, et al.
Publicado: (2023)

Drug Utilization and Potential Drug-Drug Interactions within an Intensive Care Unit at a University Tertiary Care Hospital in Egypt
por: Obeid, Dima F., et al.
Publicado: (2022)

Initiative to Improve Evidence-Based Chronic Obstructive Pulmonary Disease Hospitalist Care Using a Novel On-Line Gamification Patient Simulation Tool: A Prospective Study
por: Strong, Jodi, et al.
Publicado: (2021)

Universal Alcohol/Drug Screening in Prenatal Care: A Strategy for Reducing Racial Disparities? Questioning the Assumptions
por: Roberts, Sarah C. M., et al.
Publicado: (2010)

Contextualized Drug–Drug Interaction Management Improves Clinical Utility Compared With Basic Drug–Drug Interaction Management in Hospitalized Patients
por: Wasylewicz, Arthur T.M., et al.
Publicado: (2022)

Drug utilization, prescription errors and potential drug-drug interactions: an experience in rural Sri Lanka
por: Rathish, Devarajan, et al.
Publicado: (2016)

Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs
por: Barocas, Joshua A., et al.
Publicado: (2016)

Primary Care Prescription Drug Use and Related Actionable Drug‐Gene Interactions in the Danish Population
por: Lunenburg, Carin Adriana Theodora Catharina, et al.
Publicado: (2020)

Clinical Utility of the Adrenocorticotropin Stimulation Test with/without Dexamethasone Suppression for Definitive and Subtype Diagnosis of Primary Aldosteronism
por: Inoue, Kosuke, et al.
Publicado: (2017)

Comparative effectiveness of two disparate policies on child health: experimental evidence from the Philippines
por: Peabody, John W, et al.
Publicado: (2017)

Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia
por: Ellis, Jeffrey J, et al.
Publicado: (2014)

Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment
por: Schneider, Katharina Luise, et al.
Publicado: (2018)

Prevalence of Drug–Drug Interactions in Primary Care Prescriptions in Egypt: A Cross-Sectional Retrospective Study
por: Abdelkawy, Khaled, et al.
Publicado: (2023)

Definition and Classification of Generic Drugs Across the World
por: Alfonso-Cristancho, Rafael, et al.
Publicado: (2015)

Primary hypothyroid induced by drug interaction
por: Diarra, Martin, et al.
Publicado: (2014)

Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
por: Buchtova, Tereza, et al.
Publicado: (2023)

Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions
por: Brown, Joshua D.
Publicado: (2020)

Potential Drug-Drug Interactions in Prescriptions to Patients over 45 Years of Age in Primary Care, Southern Brazil
por: Teixeira, Jorge Juarez Vieira, et al.
Publicado: (2012)

Are We Heeding the Warning Signs? Examining Providers’ Overrides of Computerized Drug-Drug Interaction Alerts in Primary Care
por: Slight, Sarah P., et al.
Publicado: (2013)

Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications
por: Ferdinandy, Péter, et al.
Publicado: (2019)

Retrospective Drug Utilization Review: Incidence of Clinically Relevant Potential Drug-Drug Interactions in a Large Ambulatory Population
por: Peng, Catherine C., et al.
Publicado: (2003)

Equity of primary care service delivery for low income “sicker” adults across 10 OECD countries
por: Dahrouge, Simone, et al.
Publicado: (2018)

Moving on From Representativeness: Testing the Utility of the Global Drug Survey
por: Barratt, Monica J, et al.
Publicado: (2017)

An update on drug-drug interactions for care of the acutely ill in the era of COVID-19
por: Patanwala, Asad E, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vqjebhps0tbh0nks1c7e8f2e41